Significant Ownership of Growth Equity Opportunities Fund IV, LLC

Signature - Title
/s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Growth Equity Opportunities Fund IV, LLC.

Notify me when Growth Equity Opportunities Fund IV, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Growth Equity Opportunities Fund IV, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VRNA Verona Pharma plc Ordinary Shares, nominal value 0.05 GBP 5% $2,139,209,824 32,679,649 Scott D. Sandell 16 Jan 2025

Schedules 13D/G Reported by Growth Equity Opportunities Fund IV, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.